Work

Adjuvant abemaciclib for high-risk breast cancer: the story continues

Year: 2021

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.10.214

Authors: L. Spring, A. Matikas, A. Bardia, T. Foukakis

Institutions: Harvard University, Massachusetts General Hospital, Karolinska University Hospital, Karolinska Institutet

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Comprehensive Cancer Network, Cancerfonden, National Cancer Institute

Award: Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology

OpenAlex ID: W3217553653

FWCI: 0.486

Cites: 35

Cited by: 4

Related to: 10